KYinno is dedicated to oncology drug discovery service and customized product development, with a focus on immuno-oncology and next-generation kinase inhibitor discovery.

Our service platforms include:

  • Engineered custom cell line development
  • Cell-based assay validation and compound screening
  • Phage display library and hybridoma technology for antibody drug discovery
  • Cancer cell panel compound profiling and biomarker discovery
  • Our products include:

  • Engineered reporter cell lines
  • Antibody and proteins with fully validated functions in reporter cell lines
  • Our team members have years of experience in the pharmaceutical and biotechnology industry in both China and U.S.